Market Tracker

04/29 5:16pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

45.58
Delayed Data
As of Apr 29
 -1.32 / -2.81%
Today’s Change
31.25
Today|||52-Week Range
58.46
-19.43%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close46.90
Today’s open46.73
Day’s range45.09 - 47.48
Volume704,468
Average volume (3 months)1,230,343
Market cap$4.1B
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-29.63%
Earnings growth (this year)-86.43%
Earnings growth (next 5 years)-9.18%
Revenue growth (last year)--
P/E ratioNM
Price/Sales241.79
Price/Book9.53

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.05-0.32%
ICPTIntercept Pharmaceut...-2.94-1.91%
ACADACADIA Pharmaceutica...-0.10-0.31%
UTHRUnited Therapeutics ...+0.36+0.34%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 2, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$19.8M
Annual profit (last year)-$88.9M
Net profit margin-449.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts